Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
How to prepare for the Fed's forthcoming interest rate cuts
Recommended
The sun now sets before 8 p.m. Will we ever do away with the time change?
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about 5/MeO/DMT
Recent news which mentions 5/MeO/DMT
Imperial College Scientists Dose First Patient With 5-MeO-DMT To Examine One Of The Most Potent Psychedelics' Effects On The Brain
June 03, 2024
Tickers
NEWS
Tags
News
psychedelics brain
5/MeO/DMT
From
Benzinga
First Patient Dosed In Psychedelics Therapy Study For Treatment-Resistant Depression
April 26, 2024
Tickers
NEWS
Tags
BPL/003
News
Benzinga
From
Benzinga
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression
March 28, 2024
Tickers
ATAI
NEWS
Tags
News
Psychedelics Research
ATAI
From
Benzinga
GH Research: This European Biotech Company Reports Full Year 2023 Financial Results And Business Updates
February 29, 2024
Tickers
GHRS
NEWS
Tags
News
Management
Financing
From
Benzinga
Atai Invests $50M In Beckley Psytech For Short-Duration Psychedelics Development
January 04, 2024
Tickers
ATAI
GHRS
NEWS
Tags
Penny Stocks
Psychedelic/Assisted Therapies
GHRS
From
Benzinga
GH Research: Steady Expenses And $229M Cash Position For 2026 Runway
November 14, 2023
Tickers
GHRS
Tags
Psychedelics
Small Cap
News
From
Benzinga
GH Research's Psychedelic Drug Candidate For Depression Meets FDA: Clinical Program On Hold
October 02, 2023
Tickers
GHRS
Tags
FDA
Benzinga
Psychedelic/Assisted Therapies
From
Benzinga
GH Research Psychedelics Firm Q2 2023 Reports $238M Cash To Accelerate 5-MeO-DMT Programs Into 2026
August 24, 2023
Tickers
GHRS
Tags
Management
News
Markets
From
Benzinga
Harnessing The Power Of 5-MeO-DMT For Women Trauma Survivors: A Specialized Retreat
July 03, 2023
Tags
News
Management
Trauma Survivors
From
Benzinga
All On Board For 5-MeO-DMT: This Retreat Hosts Expertly Guided Experiences For Women, BIPOC
July 02, 2023
Tags
Cannabis
Market News
Benzinga
From
Benzinga
GH Research: Q1 2023 Financials And Businesses For European 5-MeO-DMT Depression Treatment Developer
May 11, 2023
Tickers
GHRS
Tags
Psychedelics
treatment/resistant depression
Biotech
From
Benzinga
Beckley Psytech Begins Phase IIa Study Of Psychedelic Compound To Treat Depression
May 04, 2023
Tags
Market News
Cannabis
Benzinga
From
Benzinga
UK-Based Approach To Alcohol Addiction: 5-MeO-DMT Candidate Moves To Phase 2 Clinical Stage
April 05, 2023
Tags
Markets
Cannabis
Market News
From
Benzinga
2 Psychedelics Companies Tout Advanced Clinical Trials, Progress With Key Products
January 11, 2023
Tickers
GHRS
PHRRF
Tags
PHRRF
Market News
Ketamine Therapy
From
Benzinga
New Sublingual Psychedelic Drug Candidate Created For Depression And Anxiety In Alzheimer's
December 29, 2022
Tickers
BMNDF
Tags
5/MeO/DMT
Drug Delivery Technologies
BMNDF
From
Benzinga
Phase 2 Trial For This Psychedelic, Potential Treatment For Severe Depression
December 22, 2022
Tags
Benzinga
Markets
Cannabis
From
Benzinga
Psychedelic Experiences: UCL Leads First-Ever Brain Imaging Study In Retreat Participants
December 07, 2022
Tags
University College London
Markets
Tandava Retreats
From
Benzinga
Beyond Magic Mushrooms: Positive Clinical Trial For Treatment-Resistant Depression & Alcoholism
November 16, 2022
Tags
Benzinga
Clinical Data
Markets
From
Benzinga
Psychedelics Company's $60M Series A For Startup To Develop Treatment For Mental Health Disorders
November 02, 2022
Tags
5/MeO/DMT
Contracts
treatment/resistant depression
From
Benzinga
Can Psychedelics Alleviate Prolonged Grief? Austin's Dell Med School Launches Clinical Trial To Find Out
October 18, 2022
Tags
Market News
Markets
Cannabis
From
Benzinga
Canadian Psychedelics Firm And Queens College Develop New Transdermal Drug Delivery System
September 27, 2022
Tickers
BMNDF
Tags
Markets
Cannabis
Queen’s University of Belfast
From
Benzinga
Clinical Study On DMT Inhaled Product For Treatment-Resistant Depression Completes Dosing Stage
September 23, 2022
Tickers
BMNDF
Tags
5/MeO/DMT
Psychedelics Therapy
Psychedelics
From
Benzinga
DMT Producer PsyBio And Shrooms Grower Red Light Holland Share Their Most Recent Financial Results
August 29, 2022
Tickers
DMT
PSYBF
TRUFF
Tags
Psychedelics
5/MeO/DMT
Global
From
Benzinga
GH Research Shares Q2 2022 Financial Results & Business Updates
August 23, 2022
Tickers
GHRS
Tags
GHRS
Benzinga
Market News
From
Benzinga
Inside A 5-MeO-DMT Retreat: Who Should And Shouldn't Embark On This 'Hero's Journey'
February 12, 2022
Tickers
DMT
Tags
DMT
Market News
Markets
From
Benzinga
5 Psychedelics For Mental Health
February 01, 2022
Tags
Benzinga
contributors
Cannabis
From
Benzinga
Beckley Psytech Begins Training Therapists For Phase 2 Trial With Toad Venom, 5-MeO-DMT
January 24, 2022
Tags
Market News
Cannabis
Markets
From
Benzinga
A Deeper Look At DMT, The 'Spirit Molecule'
January 12, 2022
Tickers
DMT
Tags
Benzinga
contributors
Cannabis
From
Benzinga
GH Research Announces Positive Trial Results For Treatment-Resistant Depression
December 06, 2021
Tickers
GHRS
Tags
GH Research
MIke Tyson
GHRS
From
Benzinga
Mike Tyson: How A Drug Derived From Toad Venom Made Him Comfortable With Dying
November 16, 2021
Tickers
GHRS
Tags
Startups
Markets
Sonoran desert toad
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.